138 related articles for article (PubMed ID: 27708419)
1. Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice.
Jemon K; Leong CM; Ly K; Young SL; McLellan AD; Hibma MH
Sci Rep; 2016 Oct; 6():34789. PubMed ID: 27708419
[TBL] [Abstract][Full Text] [Related]
2. Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.
Chandra J; Miao Y; Romoff N; Frazer IH
PLoS One; 2016; 11(3):e0152886. PubMed ID: 27031095
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis.
Abd Warif NM; Stoitzner P; Leggatt GR; Mattarollo SR; Frazer IH; Hibma MH
PLoS One; 2015; 10(5):e0127155. PubMed ID: 25992642
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.
Kuo P; Teoh SM; Tuong ZK; Leggatt GR; Mattarollo SR; Frazer IH
Front Immunol; 2018; 9():2896. PubMed ID: 30619266
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
6. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
[TBL] [Abstract][Full Text] [Related]
7. HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts.
Jazayeri SD; Kuo PT; Leggatt GR; Frazer IH
Front Immunol; 2017; 8():524. PubMed ID: 28523003
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.
Tindle RW; Herd K; Doan T; Bryson G; Leggatt GR; Lambert P; Frazer IH; Street M
J Virol; 2001 Jul; 75(13):5985-97. PubMed ID: 11390600
[TBL] [Abstract][Full Text] [Related]
9. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
10. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
11. Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response.
Zhang J; Burn C; Young K; Wilson M; Ly K; Budhwani M; Tschirley A; Braithwaite A; Baird M; Hibma M
Sci Rep; 2018 Feb; 8(1):2373. PubMed ID: 29402982
[TBL] [Abstract][Full Text] [Related]
12. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC
Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination.
Draghiciu O; Walczak M; Hoogeboom BN; Franken KL; Melief KJ; Nijman HW; Daemen T
Int J Cancer; 2014 Feb; 134(4):859-72. PubMed ID: 23922012
[TBL] [Abstract][Full Text] [Related]
15. A Genetically Modified attenuated
Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
[TBL] [Abstract][Full Text] [Related]
16. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
[TBL] [Abstract][Full Text] [Related]
17. IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes.
Hadis U; Leggatt GR; Thomas R; Frazer IH; Kovacs EM
Exp Dermatol; 2010 Aug; 19(8):723-9. PubMed ID: 20545758
[TBL] [Abstract][Full Text] [Related]
18. Tumor immunotherapy by epicutaneous immunization requires langerhans cells.
Stoitzner P; Green LK; Jung JY; Price KM; Tripp CH; Malissen B; Kissenpfennig A; Hermans IF; Ronchese F
J Immunol; 2008 Feb; 180(3):1991-8. PubMed ID: 18209098
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein.
López MC; Stanley MA
J Gen Virol; 2000 May; 81(Pt 5):1175-82. PubMed ID: 10769058
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis.
Zhou F; Leggatt GR; Frazer IH
FEBS J; 2011 Apr; 278(6):955-63. PubMed ID: 21232015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
